SearchDictionaryMobileLogin

M E R O'Brien Selected Research

SRL172

02/2005Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control.
06/2004SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results.
02/2002Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma.
02/2002A randomized pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy.

Articles by Research Topic

Disease

9Small Cell Carcinoma
03/2008 - 02/2002
5Mesothelioma
02/2006 - 02/2002
3Breast Neoplasms (Breast Cancer)
09/2005 - 03/2004
1Adenocarcinoma
01/2008
1Lung Neoplasms (Lung Cancer)
05/2004
1Weight Loss (Weight Reduction)
05/2004

Drug/Important Bio-Agent (IBA)

4SRL172IBA
02/2005 - 02/2002
2vinorelbine (Navelbine)FDA LinkGeneric
09/2005 - 06/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2005 - 03/2004
2Carboplatin (JM8)FDA LinkGeneric
06/2004 - 07/2003
1Epirubicin (Ellence)FDA LinkGeneric
09/2005
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2005
1Mitomycin (Mitomycin-C)FDA LinkGeneric
09/2004
1Vinblastine (Vinblastine Sulfate)FDA Link
09/2004
1Cisplatin (Platino)FDA LinkGeneric
09/2004
1pegylated liposomal doxorubicinIBA
03/2004
1Paclitaxel (Taxol)FDA LinkGeneric
07/2003
1amminedichloro(2- methylpyridine)platinum(II) (ZD0473)IBA
12/2002

Therapy/Procedure

13Drug Therapy (Chemotherapy)
03/2008 - 02/2002
1Immunotherapy
01/2008